News Summary

• Eyebot, a startup offering a 90-second vision test kiosk that delivers doctor-verified glasses prescriptions, has secured $20 million in Series A funding.
• The Boston-based startup, founded in 2021, streamlines how people access vision care by eliminating traditional obstacles.
• Each test generates a prescription that is then reviewed and approved by licensed eye doctors, ensuring fast, convenient, and reliable prescriptions.
• The latest round was led by General Catalyst and included participation from returning investors AlleyCorp, Baukunst, Village Global, Humba Venture, Ravelin, and Ubiquity Ventures.